Immune Complex-mediated Membranoproliferative Glomerulonephritis
📧 Sign up to get email alerts when something new happens for Immune Complex-mediated Membranoproliferative Glomerulonephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Chinese Adults With Kidney Disease [Phase 2]
ADARx Pharmaceuticals is conducting a Phase 2 trial in Chinese adults with immunoglobulin A nephropathy, C3 glomerulopathy, or immune comple…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN [Phase 3]
Phase 3 trial update on iptacopan for C3 glomerulopathy and immune-complex-mediated membranoproliferative glomerulonephritis; recruitment is…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study
Clinical trial update describing a hybrid retrospective-prospective study of outcomes in C3 glomerulopathy and immune complex-mediated membr…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: A Study of SGB-9768 in Patients with Complement-mediated Kidney Diseases [Phase 2]
A Phase 2 clinical trial of SGB-9768 for complement-mediated kidney diseases, including IgA nephropathy and C3 glomerulopathy, has not yet s…